Candriam S.C.A. - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,206,414
-11.1%
313,2620.0%0.04%
-11.9%
Q2 2023$5,857,999
+5.0%
313,262
-5.2%
0.04%
+7.7%
Q1 2023$5,580,396
-10.0%
330,399
+5.5%
0.04%
-7.1%
Q4 2022$6,202,297
-17.7%
313,2620.0%0.04%
-20.8%
Q3 2022$7,537,000
+56.2%
313,262
+18.5%
0.05%
+32.5%
Q2 2022$4,825,000
+39.1%
264,385
+67.6%
0.04%
+66.7%
Q1 2022$3,469,000157,7640.02%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$29,189,00046.08%
KPCB XV Associates, LLC 1,297,063$23,671,00043.66%
Column Group LLC 2,680,458$48,918,00010.41%
Ponoi II Management, LLC 145,401$2,654,0007.21%
Euclidean Capital LLC 432,900$7,900,0006.72%
AJU IB Investment Co., Ltd. 99,503$1,816,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,023,321$18,676,0003.17%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$8,096,0001.62%
Ghost Tree Capital, LLC 165,000$3,011,0001.57%
Perceptive Advisors 1,913,791$34,927,0001.09%
View complete list of RAPT THERAPEUTICS INC shareholders